These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 6190554

  • 1. Enhanced macromolecular binding of N-[4-(5-nitro-2-furyl)-2-thiazolyl]- formamide in germfree versus conventional rats.
    Morton KC, Wang CY.
    Cancer Res; 1983 Aug; 43(8):3628-32. PubMed ID: 6190554
    [Abstract] [Full Text] [Related]

  • 2. Biotransformation of the bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in mice.
    Swaminathan S, Bryan GT.
    Cancer Res; 1984 Jun; 44(6):2331-8. PubMed ID: 6722771
    [Abstract] [Full Text] [Related]

  • 3. Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
    Rice JR, Spry LA, Zenser TV, Davis BB.
    Cancer Res; 1988 Jan 15; 48(2):304-9. PubMed ID: 3121171
    [Abstract] [Full Text] [Related]

  • 4. Metabolism and disposition of bladder carcinogens in rat and guinea pig: possible mechanism of guinea pig resistance to bladder cancer.
    Dawley RM, Zenser TV, Mattammal MB, Lakshmi VM, Hsu FF, Davis BB.
    Cancer Res; 1991 Jan 15; 51(2):514-20. PubMed ID: 1898713
    [Abstract] [Full Text] [Related]

  • 5. Bioconversion and macromolecular binding of 2-amino-4-(5-nitro-2-furyl)thiazole by cultured rat urothelial cells.
    Swaminathan S, Johnson MD, Reznikoff CA, Bryan GT.
    Cancer Res; 1984 Dec 15; 44(12 Pt 1):5511-6. PubMed ID: 6498813
    [Abstract] [Full Text] [Related]

  • 6. Comparative effects of prostaglandin H synthase-catalyzed binding of two 5-nitrofuran urinary bladder carcinogens.
    Zenser TV, Palmier MO, Mattammal MB, Bolla RI, Davis BB.
    J Pharmacol Exp Ther; 1983 Oct 15; 227(1):139-43. PubMed ID: 6413679
    [Abstract] [Full Text] [Related]

  • 7. Effect of aspirin on urinary bladder carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
    Cohen SM, Hasegawa R, Sakata T, Johansson SL.
    Cancer Res; 1989 Jan 15; 49(2):372-7. PubMed ID: 2491954
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhancing effect of allopurinol on the induction of bladder cancer in rats by n-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Wang CY, Hayashida S, Pamukcu AM, Bryan GT.
    Cancer Res; 1976 May 15; 36(5):1551-5. PubMed ID: 1268818
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Microsomal nitroreductase activity of rabbit kidney and bladder: implications in 5-nitrofuran-induced toxicity.
    Zenser TV, Mattammal MB, Palmier MO, Davis BB.
    J Pharmacol Exp Ther; 1981 Dec 15; 219(3):735-40. PubMed ID: 6895386
    [Abstract] [Full Text] [Related]

  • 12. Metabolism and disposition of N-(4-(5-nitro-2-furyl)-(2-14-C)thiazolyl)acetamide in the rat.
    Wang CY, Chiu CW, Bryan GT.
    Drug Metab Dispos; 1975 Dec 15; 3(2):89-95. PubMed ID: 236164
    [Abstract] [Full Text] [Related]

  • 13. Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase.
    Cohen SM, Zenser TV, Murasaki G, Fukushima S, Mattammal MB, Rapp NS, Davis BB.
    Cancer Res; 1981 Sep 15; 41(9 Pt 1):3355-9. PubMed ID: 6790163
    [Abstract] [Full Text] [Related]

  • 14. Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats.
    Sakata T, Hasegawa R, Johansson SL, Zenser TV, Cohen SM.
    Cancer Res; 1986 Aug 15; 46(8):3903-6. PubMed ID: 3731063
    [Abstract] [Full Text] [Related]

  • 15. Metabolism and excretion of nitrofurothiazole bladder carcinogens.
    Spry L, Lakshmi VM, Zenser T, Davis B.
    J Pharmacol Exp Ther; 1986 Aug 15; 238(2):457-62. PubMed ID: 3735127
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced carcinogenesis by urinary tract infection in rats.
    Johansson SL, Anderström C, von Schultz L, Larsson P.
    Cancer Res; 1987 Jan 15; 47(2):559-62. PubMed ID: 3539325
    [Abstract] [Full Text] [Related]

  • 17. The effect of single dose N-methyl-N-nitrosourea on bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in rats.
    Grossman HB, Sonda LP, Lesser ML.
    Invest Urol; 1981 May 15; 18(8):457-9. PubMed ID: 7228579
    [Abstract] [Full Text] [Related]

  • 18. Effect of avitaminosis A and hypervitaminosis A on urinary bladder carcinogenicity of N-(4-(5-Nitro-2-furyl)-2-thiazolyl)formamide.
    Cohen SM, Wittenberg JF, Bryan GT.
    Cancer Res; 1976 Jul 15; 36(7 PT 1):2334-9. PubMed ID: 1277139
    [Abstract] [Full Text] [Related]

  • 19. Low susceptibility of analbuminemic rats to induction of bladder cancer by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Hosaka Y, Muramatsu M, Matsushima T, Niijima T, Nagase S.
    Jpn J Cancer Res; 1985 Jul 15; 76(7):577-82. PubMed ID: 3928553
    [Abstract] [Full Text] [Related]

  • 20. Effect of L-tryptophan and sodium saccharin on urinary tract carcinogenesis initiated by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Fukushima S, Friedell GH, Jacobs JB, Cohen SM.
    Cancer Res; 1981 Aug 15; 41(8):3100-3. PubMed ID: 7248968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.